Global Cell Therapy Program Lead - Late-Stage Oncology

Biopharma Careers; Gaithersburg (MD); Hybrid; USD 288,000 - 432,000; Full time

Job summary

AstraZeneca is seeking a Global Clinical Program Lead for late-development oncology in Gaithersburg, MD. The role oversees design, conduct and interpretation of Phase II–IV studies in prostate cancer cell therapy, collaborating with physicians, scientists and external partners to shape product strategy and regulatory submissions.

Lead cross‑functional teams, manage study execution timelines and ensure ethical, scientific rigor while advancing data-driven decisions and value demonstration for

Qualifications

• MD or life science degree.
• >5 years of clinical research experience in relevant therapy area.
• Experience in cell therapy and clinical delivery.
• Strong cross-functional collaboration and leadership.

Responsibilities

• Set vision and goals for the assigned portion of the program; align with enterprise strategy.
• Lead the design, delivery and interpretation of clinical studies; ensure ethical and scientific integrity.
• Drive Phase II–IV trial execution and monitor budget/time.
• Engage regulators, ethics committees, investigators and partners; build relationships with CROs and external experts.
• Provide robust statistical analyses to inform decisions and lifecycle opportunities.
• Promote proactive problem solving; coach team members to build future talent.

Skills

Clinical leadership

Study design

Regulatory thinking

Cross-functional teamwork

Presentation skills

Agile/PSO coordination

Education

MD or life science degree

Tools

Biostatistics

Clinical development

Payer environment

Job description

AstraZeneca is seeking a Global Clinical Program Lead for late-development oncology in Gaithersburg, MD. The role oversees design, conduct and interpretation of Phase II–IV studies in prostate cancer cell therapy, collaborating with physicians, scientists and external partners to shape product strategy and regulatory submissions.

Lead cross‑functional teams, manage study execution timelines and ensure ethical, scientific rigor while advancing data-driven decisions and value demonstration for